Providence Medical Technology closed US $25MM in new equity financing. Proceeds will support market expansion and clinical development of DTRAX® posterior cervical fusion instruments.
TranS1 announced NICE recommendation for approval of the AxiaLIF® system and presacral approach among standard arrangments to treat severe chronic low back pain.Â
SpineEx filed to raise up to US $17MM in an initial public offering to support commercialization of spinal devices, including an expandable cage for lateral lumbar fusion.
Meditech Spine gained FDA 510(k) clearance to market the CURE Opel-C Plate implant system, an add-on technology to its CURE anterior cervical plate system and Talos-C HA interbody systems.